This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Sequenom, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Innovations by Ronald Michael McCullough
Introduction
Ronald Michael McCullough is an accomplished inventor based in Encinitas, CA. He has made significant contributions to the field of genetic testing through his innovative patent. His work focuses on non-invasive methods for assessing genetic mosaicism, which has important applications in prenatal testing and oncology.
Latest Patents
McCullough holds a patent for "Methods and processes for assessment of genetic mosaicism." This technology relates to the non-invasive classification of one or more mosaic copy number variations (CNVs) in a test sample. The method involves identifying a genetic copy number variation region in sample nucleic acid, determining the fraction of nucleic acid with the copy number variation, and comparing it to a fraction of minority nucleic acid, such as fetal nucleic acid. This comparison generates a mosaicism ratio that classifies the presence or absence of genetic mosaicism.
Career Highlights
McCullough has dedicated his career to advancing genetic testing technologies. His innovative approach has the potential to improve the accuracy of non-invasive prenatal testing (NIPT) and enhance cancer diagnostics. He is currently associated with Sequenom, Inc., a company known for its pioneering work in genetic testing.
Collaborations
Some of McCullough's notable coworkers include Eyad Almasri and Jenna L Wardrop. Their collaborative efforts contribute to the ongoing advancements in genetic research and testing methodologies.
Conclusion
Ronald Michael McCullough's contributions to genetic testing through his innovative patent demonstrate his commitment to improving healthcare outcomes. His work in assessing genetic mosaicism is paving the way for more accurate and non-invasive testing methods.